EUVIMEDEUVIMED entdecken
Zurückgezogene PublikationOpen Access · CC BY 4.0

Fumagillin regulates stemness and malignancies in cancer stem-like cells derived from liver cancer via targeting to MetAP-2

Ke Zhang, Jian Hu, Ziyi Zhao iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0289024 ↗

Kurz gefasst

Zurückgezogene Publikation in der Zeitschrift PLOS ONE, 2023. Verfasst von Ke Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Second People's Hospital of Yibin, Sichuan, China. Hauptthemen laut MEDLINE: Neoplasm Recurrence, Local, Liver Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The General Program (Key Program, Major Research Plan) of National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cancer relapse is associated with the presence of cancer stem-like cells (CSCs), which lead to multidirectional differentiation and unrestricted proliferative replication. Fumagillin, a myocotoxin produced by the saprophytic filamentous fungus Aspergillus fumigatus, has been reported to affect malignant characteristics in hepatocellular cancer cells. However, its exact role in CSCs is still unknown.

Methods

CSCs were enriched by culturing cancer cells in serum-free medium. The effects of fumagillin on malignant cell characteristics and mitochondrial function were measured. The regulatory role of fumagillin on methionine aminopeptidase-2 (MetAP-2) was assessed.

Results

When it was supplemented in medium, fumagillin treatment inhibited sphere formation and the maintenance of stemness of CSCs without disturbing cell growth. Fumagillin also decreased stemness-related markers and the aldehyde dehydrogenase 1 (ALDH1)-positive proportion, which demonstrated that fumagillin decreases stemness in CSCs. It was also found to inhibit malignant traits in CSCs, including cell proliferation, invasion, and tumor formation, and sensitize CSCs to chemoagents, including sorafenib and doxorubicin, by promoting chemoagent-induced apoptosis. Moreover, fumagillin treatment was found to disturb mitochondrial membrane homeostasis, ATP synthesis and mitochondrial transcriptional activity. In addition, we found that fumagillin decreased MetAP-2 protein levels and exerted anti-CSC effects potentially by regulating MetAP-2. We also found that fumagillin treatment activated p53 and its transcriptional activity and thus caused cell cycle blockade. Moreover, fumagillin treatment significantly decreased tumor formation in nude mice.

Conclusion

This work offers evidence for fumagillin as a specific inhibitor of liver cancer CSCs and proposes a novel strategy for cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasm Recurrence, LocalLiver NeoplasmsAnimalsMiceMice, NudeAminopeptidasesCell ProliferationNeoplastic Stem CellsCell Line, TumorMetalloendopeptidasesCyclohexanesFatty Acids, UnsaturatedSesquiterpenes

Substanzen

Aminopeptidasesmethionine aminopeptidase 2MetalloendopeptidasesfumagillinCyclohexanesFatty Acids, UnsaturatedSesquiterpenes

Autor:innen und Institutionen

  • The Second People's Hospital of Yibin, Sichuan, China.
  • TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Sichuan, China.

ORCID-Profile: Ziyi Zhao

Förderung

  • The General Program (Key Program, Major Research Plan) of National Natural Science Foundation of China

Zitieren

APA

Zhang, K., Hu, J., & Zhao, Z. (2023). Fumagillin regulates stemness and malignancies in cancer stem-like cells derived from liver cancer via targeting to MetAP-2. PLOS ONE. https://doi.org/10.1371/journal.pone.0289024

Vancouver

Zhang K, Hu J, Zhao Z. Fumagillin regulates stemness and malignancies in cancer stem-like cells derived from liver cancer via targeting to MetAP-2. PLOS ONE. 2023. doi:10.1371/journal.pone.0289024

BibTeX
@article{Zhang2023,
  author = {Zhang, Ke and Hu, Jian and Zhao, Ziyi},
  title = {Fumagillin regulates stemness and malignancies in cancer stem-like cells derived from liver cancer via targeting to MetAP-2},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0289024}
}
Kostenlos starten →